Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.

Source:http://linkedlifedata.com/resource/pubmed/id/12825094

Download in:

View as

General Info

PMID
12825094